Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BioAlliance Pharma in Vax-Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

BioAlliance Pharma in Vax-Pact

Will apply mucoadhesive tech for needle-free administration

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioAlliance Pharma, a developer of orphan oncology products and supportive care products, has entered a collaboration agreement with a leading vaccine company to develop a vaccine application of its Lauriad mucoadhesive technology. The terms of the agreement were not disclosed.
 
This research program aims to establish feasibility using Lauriad technology for vaccination, leading to an efficient needle-free administration of this mucoadhesive tablet containing a vaccine antigen.
 
“This collaboration with one of the world leading vaccine companies shows the potential interest of our innovative Lauriad system for a needle-free vaccination. This is also a major step taken to increase the value of our proprietary Lauriad technology, already validated through three major products of our portfolio: Loramyc and Sitavig, already registered, and Validive, in Phase II clinical development,” said Judith Greciet, chief executive officer of BioAlliance Pharma. “A first successful feasibility would open the way to promising new opportunities in vaccine field with significant market potential worldwide.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters